Bayer to Advance Two First-of-its-Kind Investigational Cell and Gene Therapies for Parkinson's DiseaseBusiness Wire • 06/08/21
Bayer Acquires Noria and PSMA Therapeutics to Expand Pipeline in Prostate CancerBusiness Wire • 06/03/21
Bayer announces five-point plan to effectively address potential future Roundup™ claimsBusiness Wire • 05/26/21
Bayer Announces New Commercial Leaders for Crop Science Division to Accelerate Growth and Drive Business TransformationBusiness Wire • 05/18/21
Bayer Aktiengesellschaft (BAYZF) CEO Werner Baumann on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/12/21
Bayer Presents Latest Data and New Research to Advance Cancer Care within Oncology Portfolio at 2021 ASCO Annual MeetingBusiness Wire • 05/11/21
Bayer's Finerenone Meets Primary Endpoint in Phase III FIGARO-DKD Cardiovascular Outcomes Study in Patients With Chronic Kidney Disease and Type 2 DiabetesBusiness Wire • 05/10/21
Enhanced Bayer Carbon Program Offers Growers New Opportunities in 2021 and BeyondBusiness Wire • 04/19/21
Bayer to Present New Clinical Data in Indolent non-Hodgkin's Lymphoma and Additional Research on its Oncology Portfolio at AACR Annual Meeting 2021Business Wire • 04/06/21